Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunlin Zhuang

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|October 18, 2019
Small-Molecule Inhibitors of Necroptosis: Current Status and PerspectivesChunlin Zhuang, Fener Chen
Acta Pharmaceutica Sinica. B|January 1, 2026
Graph neural networks driven acceleration in drug discoveryRui Wang, Chunlin Zhuang
Medicinal Research Reviews|April 29, 2023
Profiling of small-molecule necroptosis inhibitors based on the subpockets of kinase-ligand interactionsLijuan Xu, Chunlin Zhuang
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 11, 2025
Mixed Lineage Kinase Domain-Like Protein (MLKL): From Mechanisms to Therapeutic OpportunitiesLijuan Xu, Chunlin Zhuang
Bioorganic & Medicinal Chemistry|March 5, 2024
Design, synthesis and anti-necroptosis activity of fused heterocyclic MLKL inhibitorsYining Tang, Chunlin Zhuang
Expert Opinion on Therapeutic Patents|March 24, 2023
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)Lijuan Xu, Wannian Zhang, Chunlin Zhuang
Medicinal Research Reviews|January 26, 2021
Druggability modification strategies of the diarylpyrimidine-type non-nucleoside reverse transcriptase inhibitorsLi Ding, Chunlin Zhuang, Fener Chen
Current Medicinal Chemistry|February 19, 2014
Updated research and applications of small molecule inhibitors of Keap1-Nrf2 protein-protein interaction: a reviewChunlin Zhuang, Zhenyuan Miao, Chunquan Sheng, et al.
Current Opinion in Pharmacology|November 11, 2020
Design strategies for long-acting anti-HIV pharmaceuticalsYali Sang, Li Ding, Chunlin Zhuang, et al.
Bioorganic Chemistry|December 13, 2021
Structure-Based design of Marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analoguesShuwen Han, Wei Zhou, Chunlin Zhuang, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|October 18, 2019
Small-Molecule Inhibitors of Necroptosis: Current Status and PerspectivesChunlin Zhuang, Fener Chen
Acta Pharmaceutica Sinica. B|January 1, 2026
Graph neural networks driven acceleration in drug discoveryRui Wang, Chunlin Zhuang
Medicinal Research Reviews|April 29, 2023
Profiling of small-molecule necroptosis inhibitors based on the subpockets of kinase-ligand interactionsLijuan Xu, Chunlin Zhuang
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 11, 2025
Mixed Lineage Kinase Domain-Like Protein (MLKL): From Mechanisms to Therapeutic OpportunitiesLijuan Xu, Chunlin Zhuang
Bioorganic & Medicinal Chemistry|March 5, 2024
Design, synthesis and anti-necroptosis activity of fused heterocyclic MLKL inhibitorsYining Tang, Chunlin Zhuang
Expert Opinion on Therapeutic Patents|March 24, 2023
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)Lijuan Xu, Wannian Zhang, Chunlin Zhuang
Medicinal Research Reviews|January 26, 2021
Druggability modification strategies of the diarylpyrimidine-type non-nucleoside reverse transcriptase inhibitorsLi Ding, Chunlin Zhuang, Fener Chen
Current Medicinal Chemistry|February 19, 2014
Updated research and applications of small molecule inhibitors of Keap1-Nrf2 protein-protein interaction: a reviewChunlin Zhuang, Zhenyuan Miao, Chunquan Sheng, et al.
Current Opinion in Pharmacology|November 11, 2020
Design strategies for long-acting anti-HIV pharmaceuticalsYali Sang, Li Ding, Chunlin Zhuang, et al.
Bioorganic Chemistry|December 13, 2021
Structure-Based design of Marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analoguesShuwen Han, Wei Zhou, Chunlin Zhuang, et al.
Pageof 15